The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy
Abstract
Epilepsy is characterized by recurrent epileptic seizures caused by high levels of neuronal excitability in the brain. Voltage-sensitive K+ channels (Kv) of the Kv7 (KCNQ) family encoded by the KCNQ gene are involved in a wide range of cellular processes, i.e., KCNQ2 and KCNQ3 channels mediate M-currents to inhibit neuronal excitability and reduce transmitter release throughout the nervous system. Thus, as a positive allosteric modulator (or opener) of KCNQ channels, retigabine has been the only clinically approved anti-seizure medication that acts on the KCNQ channels. This review discusses the biochemical mechanisms about how retigabine acts on Kv7 channels, significance in neuronal pathophysiology, preclinical efficacy, and clinical stage of development. Additional efforts are being made to emphasize the possible benefits and drawbacks of retigabine compared to currently available medications for treatment-resistant epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic ezogabine is associated with dose dependent dizziness, somnolence, confusion, urinary retention, and, most notably, blue or purple pigmentation of retina, nails, and skin due to drug and metabolite accumulation in melanin rich tissues [253,258,262].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [258]
In the citing paper
“Notably, agents that inhibit Kv7, including paroxetine at relevant concentrations, increase excitability and could heighten vulnerability to rebound hyperexcitability when plasticity inducers are tapered, underscoring the mechanistic rationale for Kv7-guided maintenance strategies [247,248,258].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [258]
Citations
Cites
Arzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,217
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone
Brown, D. A., & Adams, P. R. (1980) · Nature · doi:10.1038/283673a0 · Cited by 1,444
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“Multiple forms of epilepsy have been linked to dysfunctional K + channels, caused by mutations in their encoding genes [4].”
BackgroundVoltage-clamp analysis of muscarinic excitation in hippocampal neurons
Halliwell, J. V., & Adams, P. R. (1982) · Brain Research · doi:10.1016/0006-8993(82)90954-4 · Cited by 1,041
Neuronal KCNQ potassium channels:physislogy and role in disease
Jentsch, T. J. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036198 · Cited by 849
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686 · cited 1×
“Indeed, blocking M-currents depolarizes the resting membrane potential and generates action potentials [17].”
BackgroundPan, Z., Kao, T., Horvath, Z., Lemos, J., Sul, J.-Y., Cranstoun, S. D., Bennett, V., Scherer, S. S., & Cooper, E. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4314-05.2006 · Cited by 585
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy
Schroeder, B. C., Kubisch, C., Stein, V., & Jentsch, T. J. (1998) · Nature · doi:10.1038/25367 · Cited by 521
Research works printed but not linked: 5
- Serrano-Albarrás A (2018) Heteromeric composition of the Kv 1.3 channelosome= Composició heteromèrica del canalosoma Kv1. 3. Dissertation, Universitat de Barcelona
- Niday Z, Tzingounis AV (2018) Potassium channel gain of function in epilepsy: an unresolved paradox. Neurosci 24:368–380
- Cox R, McGowran M (2002) Society for Neuroscience-32nd Annual Meeting. IDrugs Investig drugs J 5:1095–1098
- Rundfeldt C (1995) Multiple actions of the new anticonvulsant D-23129 on voltage-gated inward currents and GABA-induced currents in cultured neuronal cells. Naunyn Schmiedeberg's Arch Pharmacol 351:R160
- Hermann R, Borlak J, Munzel U et al (2006) The role of Gilbert’s syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. Pharm J 6:211–219
Cited by
Targeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
“Although the clinical relevance of ezogabine’s GABAergic action has been questioned [81–86], in other experiments GABAergic effects have also been reported to occur at ezogabine concentrations as low as 1 µmol/L [91], and the possibility of GABA A receptor modulation contributing to the antiseizure…”
An update on pharmacotherapy for trigeminal neuralgia
Pergolizzi, J. V., LeQuang, J. A., El-Tallawy, S. N., Wagner, M., Ahmed, R. S., & Varrassi, G. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2365946 · Cited by 34
Retigabine increases the conformational stability of the visual photoreceptor rhodopsin
Wang, F., Fernandez-Gonzalez, P., Pérez, J. J., Morillo, M., & Garriga, P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135343 · Cited by 8
Coll, J. M. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-vlxbt · Cited by 6
Heurck, R. V., Hammar, E. B., Ville, D. M., Lebon, S., Chatron, N., Marconi, C., Royer‐Bertrand, B., Lesca, G., Superti‐Furga, A., Abramowicz, M. J., et al. (2025) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2025.04.014 · Cited by 3
Metadata
- Authors
- Zahra, A., Liu, R., Wang, J., & Wu, J.
- Affiliations
- Wuhan University of Technology (CN)
- Capital Medical University (CN)
- Corresponding author
- Wu, Jianping
- Venue
- Neurological Sciences
- Published
- 2023-07-13
- Volume
- 44
- Issue
- 11
- Pages
- 3819-3825
- ISSN
- 1590-1874 (ISSN-L)
- 1590-3478
- OpenAlex
- W4384154426
- Cited by
- 9
- References
- 66
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- retigabine, Kv7 channels, KCNQ channels, epilepsy, antiepileptic drugs, M-current, neuronal excitability, positive allosteric modulators, drug-resistant epilepsy, seizure pathophysiology
- MeSH terms
- Animals, Anticonvulsants, Carbamates, Epilepsy, Humans, Phenylenediamines, KCNQ Potassium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy. https://app.cochat.ai/papers/10.1007/s10072-023-06955-x
- The paper
- Zahra, A., Liu, R., Wang, J., & Wu, J. (2023). Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy. Neurological Sciences. https://doi.org/10.1007/s10072-023-06955-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.